In recent years, increasing concerns have emerged regarding athletes being exposed to
various sources of contamination that could result in an adverse analytical finding (AAF) …

The aim of this study was to determine the pharmacokinetics of letrozole and its effect on
FSH and LH concentrations after single (IV, IM, SC) and repeated IV doses in anestrous …

Abstract Cytochrome P450 aromatase (CYP19) catalyzes the conversion of androgens to
estrogens and is critical in sex differentiation. CYP19 exists as the ovarian type and brain …

A set of 26 naphthoquinone derivatives (3-28) were synthesized by nucleophilic substitution
or Michael addition of various amines with 1, 4-naphthoquinones and were investigated for …

Abnormal uterine bleeding (AUB) during the menopausal transition results in reproductive
endocrine disorders and both physiological and pathological changes, substantially …

Egg yolk, a major semen extender constituent, lacks a defined composition, therefore, there
are biosecurity concerns with use of egg yolk. Cryopreservation of bull semen without …

Experiments were done to determine ovulation synchrony following a 4-day letrozole
treatment (Exp 1), compare the efficacy of a letrozole-based protocol with other commonly …

Two experiments were conducted to test the effectiveness of a silicone matrix as an
intravaginal drug delivery device for letrozole, an aromatase inhibitor used for …

Effects of non-steroidal aromatase inhibitor letrozole on ovarian function in ewe were
investigated through testing the hypothesis that letrozole will arrest the growth of dominant …

Letrozole is used for the treatment of subfertility in women undergoing ovarian
superstimulation, but the mechanism of action has not been investigated critically. The …